$Evaluation of biomarkers of survival response in hormone-refractory prostate cancer patients treated with suramin$

Evaluation of biomarkers of survival response in hormone-refractory prostate cancer patients treated with suramin

Hormone-refractory prostate cancer (HRPC) patients often have nonmeasurable disease. In such patients, predictive biomarkers other than tumor response may be required to compare therapeutic effects. We examined the predictive value for survival of various clinical and laboratory parameters, includin...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer epidemiology, biomarkers & prevention biomarkers & prevention, 1998-07, Vol.7 (7), p.631-634
Hauptverfasser:	Sridhara, R, Eisenberger, M A, Sinibaldi, V J, Reyno, L M, Egorin, M J
Format:	Artikel
Sprache:	eng
Schlagworte:	Acid Phosphatase - blood Acid Phosphatase - drug effects Adult Aged Aged, 80 and over Analysis of Variance Antineoplastic Agents - pharmacology Antineoplastic Agents - therapeutic use Biomarkers, Tumor - blood Hemoglobin A - drug effects Humans L-Lactate Dehydrogenase - blood L-Lactate Dehydrogenase - drug effects Male Middle Aged Proportional Hazards Models Prostate-Specific Antigen - blood Prostate-Specific Antigen - drug effects Prostatic Neoplasms - blood Prostatic Neoplasms - drug therapy Prostatic Neoplasms - mortality Suramin - pharmacology Suramin - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!